Uploaded November 2026 | Updated November 2026, 3 days ago
University of Notre Dame Professor Hsueh-Chia Chang and his research team have developed a new blood-screening technology designed to detect four devastating illnesses—pancreatic cancer, glioblastoma, colorectal cancer, and Alzheimer’s disease—in their earliest stages.
By identifying these conditions sooner, this diagnostic innovation aims to give patients a better chance at effective treatment and survival.
Learn more about how Notre Dame researchers are working to advance human health and solve pressing global challenges:
University of Notre Dame Professor Hsueh-Chia Chang and his research team have developed a new blood-screening technology designed to detect four devastating illnesses—pancreatic cancer, glioblastoma, colorectal cancer, and Alzheimer’s disease—in their earliest stages.
By identifying these conditions sooner, this diagnostic innovation aims to give patients a better chance at effective treatment and survival.
Learn more about how Notre Dame researchers are working to advance human health and solve pressing global challenges:










